SoftOx Solutions AS , held its annual general meeting on12 May 2022 at 12:00 hours (CEST). All proposals were resolved as presented in the notice convening the annual general meeting dated5 May 2022 , as further set out in the minutes from the general meeting attached hereto. For further information, please contact: Geir Almås, CEO ofSoftOx Solutions AS , or Kristine Rød, CFO ofSoftOx Solutions AS Mail: ir@soft-ox.com Phone: Front Desk: (+47) 948-59-599 AboutSoftOx Solutions AS SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian biotech/medtech company based inOslo with the aim of helping to combat major threats to human health, namely the emergence of antimicrobial resistance (AMR), biofilm infections in chronic wounds and the spread of viruses. For more information on SoftOx, visit www.soft-ox.com. This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.
Click here for more information
© Oslo Bors ASA, source